| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | President Advanced Diagnostics | Common Stock | 128,921 | $1,929,225 | $14.96 | 23 Feb 2024 | Direct |
| NEOGENOMICS INC | President Advanced Diagnostics | Stock Option (Right to Buy) | 42,344 | $1,861,019 | $43.95 | 23 Feb 2024 | Direct |
| NEOGENOMICS INC | President Advanced Diagnostics | Performance Stock Unit | 25,330 | $379,048 | $14.96 | 23 Feb 2024 | Direct |
| NEOGENOMICS INC | President Advanced Diagnostics | Restricted Stock Unit | 25,329 | $379,033 | $14.96 | 23 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | 23 Feb 2024 | 3 | $0 | 4 | President Advanced Diagnostics | 27 Feb 2024, 16:27 |
| NEO | NEOGENOMICS INC | 01 Jun 2023 | 1 | $0 | 4 | President Advanced Diagnostics | 02 Jun 2023, 18:01 |
| NEO | NEOGENOMICS INC | 11 May 2023 | 3 | $0 | 4 | President Advanced Diagnostics | 15 May 2023, 17:05 |
| NEO | NEOGENOMICS INC | 31 Dec 2022 | 1 | +$1,584 | 5 | President, Pharma Services | 01 Feb 2023, 16:37 |
| NEO | NEOGENOMICS INC | 01 Jun 2022 | 2 | $0 | 4 | President and CCO, Inivata | 02 Jun 2022, 18:31 |
| NEO | NEOGENOMICS INC | 23 May 2022 | 0 | $0 | 3 | President and CCO, Inivata | 02 Jun 2022, 18:28 |